![]() |
市场调查报告书
商品编码
1776216
小宝宝用保温器具的全球市场:洞察,竞争情形,市场预测:2032年Baby Warming Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 |
预计在2025年至2032年的预测期内,婴儿保温设备市场将以5.72%的复合年增长率成长。婴儿保温设备的需求受到多种关键因素的驱动,包括早产数量的增加、新生儿疾病发生率的上升(包括低体温、低血糖、呼吸窘迫、代谢性酸中毒及其相关併发症),以及感染风险的增加。此外,先天性畸形盛行率的上升以及新兴市场主要公司持续的产品开发和上市活动,也进一步推动了该市场的成长。综合起来,这些因素为市场持续扩张创造了有利环境,预计婴儿保温设备市场将在2025年至2032年期间实现强劲稳定的成长。
婴儿保温器市场动态:
根据世界卫生组织 (WHO) (2024) 的数据,2022年,超过230万新生儿在出生后第一个月内死于各种新生儿疾病,包括体温过低、先天性异常、感染和神经系统疾病。新生儿,尤其是早产儿,极易快速失温,可能导致危及生命的併发症。许多此类死亡可以透过使用能够在出生后立即维持适当且稳定体温的婴儿保温器及时提供保温支持来预防。
新生儿死亡率和相关疾病发病率的上升正在推动婴儿保温器市场的成长。根据联合国儿童基金会 (2023) 的数据,全球每年约有 1,500 万婴儿(约占活产婴儿总数的十分之一)早产。 BLISS UK (2024) 的数据显示,每年有超过 1,300 万例早产,撒哈拉以南非洲和南亚地区的早产率最高。光是在英国,每年就有约 58,000 名婴儿早产。这一全球趋势正在产生对先进婴儿保温装置的强劲需求,并推动市场成长。早产儿特别容易发生新生儿体温过低,可能导致感染、呼吸窘迫甚至死亡等严重併发症。婴儿保温装置透过提供持续的热支持,在稳定这些脆弱新生儿的病情方面发挥关键作用。
除了早产之外,肺炎和败血症等其他新生儿疾病也进一步推动了市场需求。联合国儿童基金会 (UNICEF)(2024 年)报告称,全球每 10 万名儿童中有超过 1400 例肺炎,而美国国立卫生研究院 (US National Institutes of Health)(2023 年)估计,每年新生儿败血症病例数约为 130 万例。
此外,根据 Heliyon(2024 年)发表的一项研究,每年约有 110 万新生儿患上高胆红素血症(黄疸),这种情况也可能因体温过低而加剧。在这种情况下,维持稳定的温度环境对于有效治疗、免疫功能和生存至关重要。
然而,与婴儿保温装置相关的限制、严格的监管要求和产品召回是可能限制婴儿保温装置市场成长的关键限制因素。
婴儿保温器市场细分分析:
依产品类型划分的婴儿保温器市场中,辐射保温器类别预计在2024年占据最大市场占有率。此类别的成长主要得益于新生儿疾病发病率的上升以及婴儿辐射保温器在新生儿护理中提供的临床益处。新生儿,尤其是早产儿,极易快速散热,这会增加他们的低体温症风险,而低体温症是一种可能危及生命的疾病。新生儿辐射保温器提供了一个可控的开放式护理环境,有助于在医疗评估、復苏和治疗程序等关键时刻维持稳定的体温。
辐射保温器的一项显着临床益处是其能够根据婴儿的皮肤温度自动调节热量输出。这些系统使用内建皮肤温度探头提供即时回馈,实现精确的温度控制,最大限度地降低过热和欠热的风险,并确保持续、安全的热环境。辐射加温器的另一个主要优点是其开放式设计。由于婴儿被安置在开放式的病床上,医护人员可以不间断地检查、復苏并执行任何必要的干预措施。
市场上先进且广泛采用的辐射加温器包括 GE HealthCare 的 Giraffe Warmer 和 Drager 的 Bebiloo® TN300。这些设备具有旋转床垫等功能,方便婴儿接触,并整合皮肤温度监测器,可持续调节温度。这些技术创新旨在减少不必要的刺激并改善护理人员的工作流程,使其在新生儿加护病房 (NICU) 和产房中非常有效。
黄疸等新生儿疾病负担的日益恶化也推动了对辐射加温器的需求成长。黄疸新生儿,尤其是早产儿和低出生体重儿,通常需要光疗,在此期间维持最佳体温至关重要。辐射加温器在整个光疗过程中对维持体温稳定、确保安全并改善治疗效果起着关键作用。
这些因素预计将推动细分市场的发展,并最终推动全球婴儿保暖设备市场的发展。
预计到2024年,北美将占据婴儿保暖设备市场的最大占有率,这主要得益于几个关键因素。该地区的主导地位主要归因于新生儿疾病的高发病率、早产率高以及先天性异常发病率的上升。其他优势包括该地区完善的医疗保健基础设施和市场领导企业的强大影响力。这些因素共同使北美成为全球婴儿保暖设备市场的领导市场。
根据美国疾病管制与预防中心 (CDC, 2023) 的数据,2022 年美国约有十分之一的婴儿早产,相当于每年约有 38 万名早产儿。早产儿由于体温调节系统发育不全,特别容易发生低体温症。婴儿保温设备对于维持稳定的体温并降低早期治疗期间发生严重併发症的风险至关重要。
先天性异常盛行率的上升进一步增加了对婴儿保温设备的需求。根据 CDC (2024) 的数据,心臟病仍然是美国最常见的先天性异常,影响约 1% 的活产婴儿,即每年约有 4 万名婴儿。此外,大约每2,400名新生儿中就有1名会发生胃造口术等情况,通常需要立即进行手术干预和长期的新生儿护理,因此需要准确且一致的婴儿保温设备来支持復健并预防併发症。
根据美国疾病管制与预防中心 (CDC) 2024 年的数据,总体而言,美国大约每33名新生儿中就有1名患有先天性异常,每年约有12万例。这些新生儿通常需要早期介入和先进的新生儿支援技术,而婴儿保温设备在维持关键操作过程中的体温稳定方面发挥关键作用。患有先天性缺陷的新生儿通常由于低出生体重和生理紊乱而容易发生低体温,因此有效的体温调节对他们的生存和康復至关重要。
此外,新生儿黄疸也显着增加了对婴儿保温设备的需求。根据美国国立卫生研究院 (2023) 的数据,约 60% 的足月新生儿和 80% 的早产儿在出生后第一週内会出现临床黄疸。这些新生儿通常需要接受光疗,在此期间,婴儿保温装置对于维持体温稳定、提高治疗效果以及确保新生儿的舒适度和安全至关重要,从而推动了市场扩张。
此外,北美拥有强大的医疗基础设施、广泛的先进医疗技术,以及 GE 医疗、Drager 和 Natus Medical 等行业领导者的影响力。这些公司透过提供高品质、技术先进的婴儿保温解决方案,持续推动新生儿护理领域的创新,进一步促进市场成长。
总体而言,早产、先天性异常和新生儿疾病负担的不断加重,加上强大的行业支持和医疗保健能力,正在推动北美对婴儿保温装置的需求,巩固其在全球市场领先地位。
婴儿保温器市场的主要参与者
婴儿保温器市场的主要参与者包括通用电气医疗集团 (GE HealthCare)、荷兰皇家飞利浦公司 (Koninklijke Philips N.V.)、Dragerwerk AG & Co. KGaA、康德乐 (Cardinal Health)、纳特斯医疗公司 (Natus Medical Incorporated)、Atom Medical Corp.、NOVOS Medical Corp. Ltd.、Phoenix Medical Systems、Medical Technology Transfer and Services Asia (MTTS)、DAVID、nice Neotech Medical Systems Pvt. Ltd.、北京聚龙三友科技有限公司 (Beijing Julongsanyou Technology Co. Ltd.)、Advin Health Care、南京爱美斯医疗科技有限公司 (Nanjing AMIS Medical Technology Co. Ltd.)、Heak Medical Ltd.
婴儿保温设备市场的最新发展:
婴儿保暖器市场研究报告重点
婴儿保暖器市场常见问题
Baby Warming Devices Market by Product Type (Radiant Warmers, Incubators, and, Others), End-User (Hospitals, Pediatric & Maternity Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increase in number of neonatal disorders & preterm birth and increasing product development and launches activities by key players.
The baby warming devices market is estimated to grow at a CAGR of 5.72% during the forecast period from 2025 to 2032. The demand for baby warming devices is being driven by several critical factors, including the rising incidence of neonatal disorders such as hypothermia and related complications like hypoglycemia, respiratory distress, metabolic acidosis, and increased risk of infections, along with the growing number of preterm births. Additionally, the increasing prevalence of congenital anomalies and ongoing product development and launch activities by leading market players are further fueling growth. Collectively, these factors are creating a supportive environment for sustained market expansion, positioning the baby warming devices market for robust and steady growth from 2025 to 2032.
Baby Warming Devices Market Dynamics:
According to the World Health Organization (2024), more than 2.3 million newborns died within the first month of life in 2022 due to a range of neonatal conditions, including hypothermia, congenital anomalies, infections, and neurological disorders. Newborns, particularly preterm infants, are highly vulnerable to rapid heat loss, which can lead to life-threatening complications. Many of these deaths could be prevented with timely thermal support using baby warming devices, which help maintain an adequate and stable body temperature immediately after birth.
The rising incidence of neonatal mortality and associated conditions is a key driver of growth in the baby warming devices market. According to UNICEF (2023), approximately 15 million babies, about 1 in 10 births globally, are born prematurely each year. Data from BLISS UK (2024), reported over 13 million preterm births annually, with the highest prevalence in sub-Saharan Africa and Southern Asia. In the United Kingdom alone, around 58,000 babies are born prematurely each year. This global trend has created a strong and growing demand for advanced baby warming devices, thereby propelling market growth. Preterm infants are particularly susceptible to neonatal hypothermia, a condition that can lead to severe complications such as infections, respiratory distress, and even death. Baby warming devices play a critical role in stabilizing these vulnerable newborns by providing consistent thermal support.
In addition to prematurity, other neonatal conditions such as pneumonia and sepsis are further fueling market demand. UNICEF (2024) reported over 1,400 cases of pneumonia per 100,000 children globally, while the National Institutes of Health (2023) estimated around 1.3 million annual cases of neonatal sepsis.
Moreover, a study published in Heliyon (2024), found that approximately 1.1 million newborns developed hyperbilirubinemia (jaundice) each year, a condition that can also worsen with hypothermia. Maintaining a temperature-stable environment is essential for effective treatment, immune function, and survival in these cases.
However, the limitations associated with baby warming devices and stringent regulatory requirements and product recalls, among others are some of the key constraints that may limit the growth of the baby warming devices market.
Baby Warming Devices Market Segment Analysis:
Baby Warming Devices Market by Product Type (Radiant Warmers, Incubators, and, Others), End-User (Hospitals, Pediatric & Maternity Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the baby warming devices market, the radiant warmers category is estimated to account for the largest market share in 2024. The growth of the category is primarily driven by the rising incidence of neonatal conditions and the clinical advantages that infant radiant warmers offer in neonatal care. Newborns, especially those born prematurely, are highly susceptible to rapid heat loss, increasing the risk of hypothermia, a serious and potentially life-threatening condition. Infant radiant warmers provide a controlled, open-care environment that helps maintain stable body temperature during critical moments such as medical assessments, resuscitation, or treatment procedures.
A major clinical advantage of radiant warmers is their ability to automatically regulate heat output based on the infant's skin temperature. These systems use integrated skin temperature probes to deliver real-time feedback, enabling precise heat adjustments that ensure a consistent and safe thermal environment minimizing the risk of both overheating and underheating. Another key benefit of radiant warmers is their open-access design. Infants are placed on an open bed, allowing unobstructed access for healthcare providers to examine, resuscitate, or perform necessary interventions without interference, which is especially crucial in emergency and intensive care settings.
Several advanced and widely adopted radiant warmers on the market include the Giraffe Warmer by GE HealthCare and the Babyroo(R) TN300 by Drager. These devices are equipped with features like rotating mattresses for convenient infant access and integrated skin temperature monitoring for continuous thermal regulation. Such innovations are designed to reduce unnecessary stimulation and improve caregiver workflow, making them highly effective for use in NICUs and delivery rooms.
The growing burden of neonatal conditions such as jaundice is also contributing to the increasing demand for radiant warmers. Jaundiced infants, particularly those born prematurely or with low birth weight, often require phototherapy, during which maintaining optimal body temperature is essential. Radiant warmers play a critical role in preserving thermal stability throughout the phototherapy process, ensuring safety and improving treatment outcomes.
Thus, the factors mentioned above are likely to boost the market segment and thereby increase the overall market of baby warming devices across the globe.
North America is expected to dominate the overall baby warming devices market:
North America is projected to hold the largest share of the baby warming devices market in 2024, driven by several key factors. This regional dominance is primarily attributed to the high prevalence of neonatal disorders, a significant rate of preterm births, and the growing incidence of congenital anomalies. Additionally, the region benefits from a well-established healthcare infrastructure and the strong presence of leading market players, which further supports product adoption and accessibility. Collectively, these factors are positioning North America as the leading market in the global baby warming devices market.
According to the Centers for Disease Control and Prevention (CDC, 2023), in 2022, approximately 1 in 10 babies, equated to nearly 380,000 preterm births annually were born prematurely in the United States. Preterm infants are especially vulnerable to hypothermia due to their underdeveloped thermoregulatory systems, making infant warming devices critical in maintaining stable body temperatures and reducing the risk of serious complications during early care.
The demand for baby warming devices is further strengthened by the growing prevalence of congenital anomalies. The CDC data (2024), highlighted that heart defects remain the most common birth defects in the United States, affecting about 1% of births, or roughly 40,000 babies each year. In addition, conditions like gastroschisis, occurring in approximately 1 in every 2,400 births, often require immediate surgical intervention and extended neonatal care, necessitating precise and consistent baby warming devices to support recovery and prevent complications.
Overall, congenital anomalies affect approximately 1 in every 33 babies in the U.S., accounting for around 120,000 cases annually, according to CDC (2024). These newborns frequently need early intervention and advanced neonatal support technologies, with baby warming devices playing a vital role in maintaining thermal stability during critical procedures. Infants affected by birth defects are often more susceptible to hypothermia due to low birth weight and physiological impairments, making effective thermal regulation essential for survival and recovery.
Additionally, neonatal jaundice significantly contributes to the demand for baby warming devices. According to the National Institutes of Health (2023), approximately 60% of term and 80% of preterm newborns developed clinical jaundice within the first week of life. These infants often undergo phototherapy, during which baby warming devices are essential to maintain a stable body temperature, enhancing treatment effectiveness and ensuring the infant's comfort and safety, thereby driving the market expansion.
Moreover, North America also benefits from a robust healthcare infrastructure, widespread access to advanced medical technologies, and the presence of key industry players such as GE HealthCare, Drager, and Natus Medical. These companies continue to drive innovation in neonatal care by offering high-quality, technologically advanced infant warming solutions, further contributing to market growth.
Collectively, the rising burden of preterm births, congenital anomalies, and neonatal conditions, combined with strong industry support and healthcare capabilities, is propelling the demand for baby warming devices in North America, reinforcing its position as a leading region in global market.
Baby Warming Devices Market Key Players:
Some of the key market players operating in the baby warming devices market include GE HealthCare, Koninklijke Philips N.V., Dragerwerk AG & Co. KGaA, Cardinal Health, Natus Medical Incorporated, Atom Medical Corp., NOVOS, Maternova Inc., Fanem, Weyer GmbH, VNG Medical Innovation System Pvt Ltd., Phoenix Medical Systems, Medical Technology Transfer and Services Asia (MTTS), DAVID, nice Neotech Medical Systems Pvt. Ltd., Beijing Julongsanyou Technology Co., Ltd., Advin Health Care, Nanjing AMIS Medical Technology Co., Ltd., Healicom Medical Equipment Co., Ltd., Narang Medical Limited, and others.
Recent Developmental Activities in the Baby Warming Devices Market:
Key takeaways from the baby warming devices market report study
Target audience who can benefit from this baby warming devices market report study
Frequently Asked Questions for the Baby Warming Devices Market: